News Conference News ACC 2021 ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19 Todd Neale May 17, 2021
News Daily News VTE Risk Higher After Oxford/AstraZeneca COVID-19 Vaccine, Study Affirms Todd Neale May 06, 2021
News Conference News SCAI 2021 In African-American Patients, Nontraditional Risk Factors Track With Early CAD Michael O'Riordan April 28, 2021
News Daily News In Female Veterans With Early ASCVD, Secondary Prevention Falls Short Michael O'Riordan April 21, 2021
News Daily News Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI Yael L. Maxwell April 09, 2021
News Daily News Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms Michael O'Riordan April 02, 2021
News Features Roughly 80% of ESC Guideline Writers Have Financial COIs Michael O'Riordan April 01, 2021
News Daily News Experts Fear Coronary CT Advice for Patients Misses the Mark Michael O'Riordan March 19, 2021
News Daily News Little Improvement Seen Over Two Decades in US Racial Health Disparities L.A. McKeown March 15, 2021
News Daily News Smoking, Drinking, and Drugs—All Signs Point to Earlier ASCVD Michael O'Riordan February 19, 2021
News Daily News Prophylactic Anticoagulation, Fewer Deaths in Hospitalized COVID-19 Patients Michael O'Riordan February 15, 2021
News Features The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive Todd Neale February 08, 2021
News Daily News Afternoon Blahs? Statin Prescriptions More Likely for Early-Day Patients Michael O'Riordan February 01, 2021
News Daily News Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups Todd Neale February 01, 2021
News Daily News CAC Screening Cost-effective for Statin Decisions in Hereditary CAD Michael O'Riordan January 14, 2021
News Daily News Checklist for Same-Day Discharge PCI Stresses Buy-In, and a Plan Shelley Wood January 07, 2021
News Features The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations L.A. McKeown December 24, 2020